Real-world safety and clinical outcomes of apixaban in patients with cancer and atrial fibrillation.

Alabdelmuhsin LS, Alwethairi MF, Alharbi D, Almadani OA, Badreldin HA, Alfehaid L

Open source

DOI
10.3389/fcvm.2026.1893856
Published
2026
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1893856,
  title = {Real-world safety and clinical outcomes of apixaban in patients with cancer and atrial fibrillation.},
  author = {Alabdelmuhsin LS and Alwethairi MF and Alharbi D and Almadani OA and Badreldin HA and Alfehaid L},
  year = {2026},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2026.1893856},
  url = {https://doi.org/10.3389/fcvm.2026.1893856}
}

RIS

TY  - JOUR
TI  - Real-world safety and clinical outcomes of apixaban in patients with cancer and atrial fibrillation.
AU  - Alabdelmuhsin LS
AU  - Alwethairi MF
AU  - Alharbi D
AU  - Almadani OA
AU  - Badreldin HA
AU  - Alfehaid L
PY  - 2026
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.1893856
UR  - https://doi.org/10.3389/fcvm.2026.1893856
ER  - 

APA

LS, A., MF, A., D, A., OA, A., HA, B., & L, A. (2026). Real-world safety and clinical outcomes of apixaban in patients with cancer and atrial fibrillation.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.1893856

Source records